BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27596143)

  • 1. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
    Jiang MC
    Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSE1L Links cAMP/PKA and Ras/ERK pathways and regulates the expressions and phosphorylations of ERK1/2, CREB, and MITF in melanoma cells.
    Lee WR; Shen SC; Wu PR; Chou CL; Shih YH; Yeh CM; Yeh KT; Jiang MC
    Mol Carcinog; 2016 Nov; 55(11):1542-1552. PubMed ID: 26331446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
    Liao CF; Lin SH; Chen HC; Tai CJ; Chang CC; Li LT; Yeh CM; Yeh KT; Chen YC; Hsu TH; Shen SC; Lee WR; Chiou JF; Luo SF; Jiang MC
    Mol Med; 2012 Dec; 18(1):1269-80. PubMed ID: 22952058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.
    Tai CJ; Hsu CH; Shen SC; Lee WR; Jiang MC
    J Exp Clin Cancer Res; 2010 Aug; 29(1):110. PubMed ID: 20701792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
    Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
    J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
    Lee WR; Shen SC; Shih YH; Chou CL; Tseng JT; Chin SY; Liu KH; Chen YC; Jiang MC
    J Transl Med; 2015 Jun; 13():191. PubMed ID: 26070816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
    Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
    Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
    Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
    Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
    Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
    FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
    Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
    Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSE1L/CAS: its role in proliferation and apoptosis.
    Behrens P; Brinkmann U; Wellmann A
    Apoptosis; 2003 Jan; 8(1):39-44. PubMed ID: 12510150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs.
    Liao CF; Luo SF; Shen TY; Lin CH; Chien JT; Du SY; Jiang MC
    BMB Rep; 2008 Mar; 41(3):210-6. PubMed ID: 18377724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells.
    Tai CJ; Shen SC; Lee WR; Liao CF; Deng WP; Chiou HY; Hsieh CI; Tung JN; Chen CS; Chiou JF; Li LT; Lin CY; Hsu CH; Jiang MC
    Exp Cell Res; 2010 Oct; 316(17):2969-81. PubMed ID: 20688056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSE1L promotes proliferation and migration in oral cancer through positively regulating MITF.
    Wang YS; Peng C; Guo Y; Li Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5429-5435. PubMed ID: 32495878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
    Jiang MC; Luo SF; Li LT; Lin CC; Du SY; Lin CY; Hsu YW; Liao CF
    J Exp Clin Cancer Res; 2007 Mar; 26(1):91-9. PubMed ID: 17550137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
    Liao CF; Luo SF; Li LT; Lin CY; Chen YC; Jiang MC
    J Exp Clin Cancer Res; 2008 Jul; 27(1):15. PubMed ID: 18597698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
    Yuksel UM; Turker I; Dilek G; Dogan L; Gulcelik MA; Oksuzoglu B
    Oncol Res Treat; 2015; 38(9):431-4. PubMed ID: 26278417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
    Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
    Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
    Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
    J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.